Cite
Extracellular vesicle‐encapsulated microRNA‐425‐derived from drug‐resistant cells promotes non‐small–cell lung cancer progression through DAPK1‐medicated PI3K/AKT pathway.
MLA
Guo, Zhihua, et al. “Extracellular Vesicle‐encapsulated MicroRNA‐425‐derived from Drug‐resistant Cells Promotes Non‐small–cell Lung Cancer Progression through DAPK1‐medicated PI3K/AKT Pathway.” Journal of Cellular Physiology, vol. 236, no. 5, May 2021, pp. 3808–20. EBSCOhost, https://doi.org/10.1002/jcp.30126.
APA
Guo, Z., Ye, H., Zheng, X., Yin, W., & He, J. (2021). Extracellular vesicle‐encapsulated microRNA‐425‐derived from drug‐resistant cells promotes non‐small–cell lung cancer progression through DAPK1‐medicated PI3K/AKT pathway. Journal of Cellular Physiology, 236(5), 3808–3820. https://doi.org/10.1002/jcp.30126
Chicago
Guo, Zhihua, Huangyang Ye, Xiaobin Zheng, Weiqiang Yin, and Jianxing He. 2021. “Extracellular Vesicle‐encapsulated MicroRNA‐425‐derived from Drug‐resistant Cells Promotes Non‐small–cell Lung Cancer Progression through DAPK1‐medicated PI3K/AKT Pathway.” Journal of Cellular Physiology 236 (5): 3808–20. doi:10.1002/jcp.30126.